Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome

References

• Abraham NG, Kappas A. (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79–127
   PubMed Web of Science ®Google Scholar
• Balletshofer BM, Rittig K, Stock J, et al. (2003). Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 171:303–9
   PubMed Web of Science ®Google Scholar
• Beckman JS. (1996). Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836–44
   PubMed Web of Science ®Google Scholar
• Berkowitz DE, White R, Li D, et al. (2003). Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108:2000–6
   PubMed Web of Science ®Google Scholar
• Bimenya GS, Nzarubara GR, Kiconco J, et al. (2003). The accuracy of self monitoring blood glucose meter systems in Kampala Uganda. Afr Health Sci 3:23–32
   PubMedGoogle Scholar
• Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC. (2001). Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283:923–7
   PubMed Web of Science ®Google Scholar
• Blakely SR, Hallfrisch J, Reiser S, Prather ES. (1981). Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr 111:307–14
   PubMed Web of Science ®Google Scholar
• Busija DW, Miller AW, Katakam P, Erdos B. (2006). Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid Redox Signal 8:1131–40
   PubMed Web of Science ®Google Scholar
• Cao J, Inoue K, Li X, et al. (2009). Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol 41:1025–33
   PubMed Web of Science ®Google Scholar
• Carmassi F, De Negri F, Fioriti R, et al. (2005). Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome. Thromb Res 116:207–14
   PubMed Web of Science ®Google Scholar
• Chen H. (2006). Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53:469–77
   PubMed Web of Science ®Google Scholar
• Cosenzi A, Bernobich E, Plazzotta N, et al. (1999). Bosentan reduces blood pressure and the target-organ damage induced by a high-fructose diet in rats. J Hypertens 17:1843–8
   PubMed Web of Science ®Google Scholar
• Dai S, McNeill JH. (1995). Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods 33:101–7
   PubMed Web of Science ®Google Scholar
• Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H. (1987). Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized m-mode echocardiography. Am J Cardiol 60:143–6
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Verbeuren TJ, Van de Voorde J, et al. (2000). Endothelial dysfunction in diabetes. Br J Pharmacol 130:963–74
   PubMed Web of Science ®Google Scholar
• Delbosc S, Paizanis E, Magous R, et al. (2005). Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179:43–9
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, Abo-Warda SM, Fahmy A. (2012a). Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. Clin Exp Pharmacol Physiol 39:643–9
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, El-Fawal R, Fahmy A, Watson ML. (2013). Arginase inhibition alleviates hypertension in the metabolic syndrome. Br J Pharmacol 169:693–703
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, El-Moselhy MA, Mahmoud MF. (2011a). Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol 384:277–85
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, Fahmy A, Badawy D. (2011b). Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol 49:3007–12
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, Fahmy A, El-Fawal R. (2012b). Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol 57:194–200
   PubMed Web of Science ®Google Scholar
• Erdos B, Miller AW, Busija DW. (2002). Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Heart Circ Physiol 282:H2060–5
   Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonadonna R, et al. (1987). Insulin resistance in essential hypertension. N Engl J Med 317:350–7
   PubMed Web of Science ®Google Scholar
• Fossati P, Prencipe L, Berti G. (1980). Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 26:227–31
   PubMed Web of Science ®Google Scholar
• Fukuyama N, Homma K, Wakana N, et al. (2008). Validation of the Friedewald equation for evaluation of plasma LDL-cholesterol. J Clin Biochem Nutr 43:1–5
   PubMed Web of Science ®Google Scholar
• Hallfrisch J, Ellwood KC, Michaelis OE IV, et al. (1983). Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr 113:1819–26
   PubMed Web of Science ®Google Scholar
• Hassan N, El-Bassossy HM, Zakaria MNM. (2013). Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility. Naunyn Schmiedebergs Arch Pharmacol 386:217–26
   PubMed Web of Science ®Google Scholar
• Hwang IS, Ho H, Hoffman BB, Reaven GM. (1987). Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512–16
   PubMed Web of Science ®Google Scholar
• Iyer SN, Katovich MJ. (1996). Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exp Hypertens 18:227–42
   PubMed Web of Science ®Google Scholar
• Katakam PV, Ujhelyi MR, Hoenig ME, Miller AW. (1998). Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Regul Integr Comp Physiol 275:R788–92
   PubMed Web of Science ®Google Scholar
• Lakka HM, Lakka TA, Tuomilehto J, et al. (2000). Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 160:1160–8
   PubMedGoogle Scholar
• Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. (2013). Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One 8:2013
   Web of Science ®Google Scholar
• Marks JB, Raskin P. (2000). Cardiovascular risk in diabetes: a brief review. J Diab Comp 14:108–15
   Google Scholar
• McKendrick JD, Salas E, Dube GP, et al. (1998). Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats. Br J Pharmacol 124:361–9
   PubMed Web of Science ®Google Scholar
• Nagele U, Hagele EO, Sauer G, et al. (1984). Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 22:165–74
   PubMedGoogle Scholar
• Nisoli E, Clementi E, Carruba MO, Moncada S. (2007). Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100:795–806
   PubMed Web of Science ®Google Scholar
• Pedersen TR. (1998). Coronary artery disease: the Scandinavian Simvastatin Survival Study experience. Am J Cardiol 82:53T–6
   PubMed Web of Science ®Google Scholar
• Pombo Gregoire I, Correia AM, Soares MP. (2006). Tu-P7:62 Heme oxygenase-1 derived carbon monoxide inhibits atherosclerosis. Atheroscler Suppl 7:198–9
   Web of Science ®Google Scholar
• Reaven GM. (1991). Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 90:7S–12S
   PubMed Web of Science ®Google Scholar
• Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. (2000). Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 36:423–9
   PubMed Web of Science ®Google Scholar
• Robins SJ. (2001). Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial. Am J Cardiol 88:19N–23N
   PubMed Web of Science ®Google Scholar
• Romero MJ, Platt DH, Tawfik HE, et al. (2008). Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102:95–102
   PubMed Web of Science ®Google Scholar
• Sampathkumar R, Balasubramanyam M, Rema M, et al. (2005). A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism 54:1002–7
   PubMed Web of Science ®Google Scholar
• Shinozaki K, Ayajiki K, Nishio Y, et al. (2004). Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43:255–62
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Chaker H, Leaming R, et al. (1996). Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601–10
   PubMed Web of Science ®Google Scholar
• Takagawa Y, Berger ME, Hori MT, et al. (2001). Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am J Hypertens 14:811–17
   PubMed Web of Science ®Google Scholar
• Tan Hw, Liu X, Bi Xp, et al. (2010). IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome. Atherosclerosis 208:350–7
   PubMed Web of Science ®Google Scholar
• Tobey TA, Mondon CE, Zavaroni I, Reaven GM. (1982). Mechanism of insulin resistance in fructose-fed rats. Metabolism 31:608–12
   PubMed Web of Science ®Google Scholar
• Togashi N, Ura N, Higashiura K, et al. (2002). Effect of TNF-{alpha}-converting enzyme inhibitor on insulin resistance in fructose-fed rats. Hypertension 39:578–80
   PubMed Web of Science ®Google Scholar
• Ugochukwu NH, Cobourne MK. (2003). Modification of renal oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with extracts from Gongronema latifolium leaves. Clin Chim Acta 336:73–81
   PubMed Web of Science ®Google Scholar
• Verma S, Bhanot S, Yao L, McNeill JH. (1996). Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 9:370–6
   PubMed Web of Science ®Google Scholar
• Viswanad B, Srinivasan K, Kaul CL, Ramarao P. (2006). Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 53:209–15
   PubMed Web of Science ®Google Scholar
• Wolff SP, Dean RT. (1987). Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation' in diabetes. Biochem J 245:243–50
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Hansson L, Dahlof B, et al. (2001). Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens 19:1149–59
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Sander S, Scott S, Reaven GM. (1980). Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29:970–3
   PubMed Web of Science ®Google Scholar